PAPER Grenier A, O'Connor D, James K, Imahori D, Minchopoulos D, Velev N, Tamblyn-Watts L, Mann J
SEARCH RESULTS
332559 RESULTS
PAPER Singh K, Gupta JK, Jain D, Kumar S, Saha S, Sharma A
Exploring Therapeutic Frontiers: Unveiling the Potential of Natural Diterpenoid Derivatives in Addressing Neurological Disorders.
Curr Pharm Biotechnol. 2024 May 17; PubMed.PAPER Zhao XY, Xu DE, Wu ML, Liu JC, Shi ZL, Ma QH
Regulation and function of endoplasmic reticulum autophagy in neurodegenerative diseases.
Neural Regen Res. 2025 Jan 1;20(1):6-20. Epub 2024 Jan 31 PubMed.PAPER Zhang M, Li Y, Han C, Chu S, Yu P, Cheng W
Biosynthesis of Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation Coupled with Ligands Analysis.
Int J Nanomedicine. 2024;19:4299-4317. Epub 2024 May 14 PubMed.PAPER Wu J, Mao M, Yang J, Li K, Deng P, Zhong J, Wu X, Cheng Y
Development of an 18F-labeled azobenzothiazole tracer for α-synuclein aggregates in the brain.
Org Biomol Chem. 2024 May 20; PubMed.PAPER Clausen L, Okarmus J, Voutsinos V, Meyer M, Lindorff-Larsen K, Hartmann-Petersen R
PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants.
Cell Mol Life Sci. 2024 May 20;81(1):223. PubMed.PAPER Guo X, Yang YY, Zhou R, Tian G, Shan C, Liu JM, Li R
Causal effect of blood osteocalcin on the risk of Alzheimer's disease and the mediating role of energy metabolism.
Transl Psychiatry. 2024 May 20;14(1):205. PubMed.PAPER Jin P, Li Y, Li Y
Meta-analysis of the association between C9orf72 repeats and neurodegeneration diseases.
J Neurogenet. 2024 May 20;:1-8. PubMed.PAPER Gurdon B, Yates SC, Csucs G, Groeneboom NE, Hadad N, Telpoukhovskaia M, Ouellette A, Ouellette T, O'Connell KM, Singh S, Murdy TJ, Merchant E, Bjerke I, Kleven H, Schlegel U, Leergaard TB, Puchades MA, Bjaalie JG, Kaczorowski CC
Detecting the effect of genetic diversity on brain composition in an Alzheimer's disease mouse model.
Commun Biol. 2024 May 20;7(1):605. PubMed.PAPER Jiao F, Meng L, Du K, Li X
The autophagy-lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson's disease.
Neural Regen Res. 2025 Jan 1;20(1):139-158. Epub 2024 Jan 31 PubMed.PAPER Moguilner SG, Berezuk C, Bender AC, Pellerin KR, Gomperts SN, Cash SS, Sarkis RA, Lam AD
Sleep functional connectivity, hyperexcitability, and cognition in Alzheimer's disease.
Alzheimers Dement. 2024 May 19; PubMed.PAPER Yang P, Li Y, Qian K, Zhou L, Cheng Y, Wu J, Xu M, Wang T, Yang X, Mu Y, Liu X, Zhang Q
Precise Modulation of Pericyte Dysfunction by a Multifunctional Nanoprodrug to Ameliorate Alzheimer's Disease.
ACS Nano. 2024 May 20; PubMed.PAPER Zhu HH, Wang YC, He LC, Luo HY, Zong C, Yang YH, Wu JH, Song B, Gao Y, Xu YM, Li YS
Novel inflammatory and insulin resistance indices provide a clue in cerebral amyloid angiopathy.
Sci Rep. 2024 May 20;14(1):11474. PubMed.PAPER Arena G, Landoulsi Z, Grossmann D, Payne T, Vitali A, Delcambre S, Baron A, Antony P, Boussaad I, Bobbili DR, Sreelatha AA, Pavelka L, J Diederich N, Klein C, Seibler P, Glaab E, Foltynie T, Bandmann O, Sharma M, Krüger R, May P, Grünewald A, NCER‐PD and COURAGE‐PD Consortia
Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.
Ann Neurol. 2024 May 20; PubMed.PAPER Li R, Yao S, Wei F, Chen M, Zhong Y, Zou C, Chen L, Wei L, Yang C, Zhang X, Liu Y
Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis.
Sci Rep. 2024 May 20;14(1):11487. PubMed.Current Filters
No filters selected